SEC Form 4 · accession 0000939767-17-000075

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael Morrissey

Officer — President and CEO · Director

Period of report

May 3, 2017

Accepted (ET)

May 5, 2017 · 6:53 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	May 3, 2017	M	69,427	$1.90	A	129,427	D
Common Stock^F2	May 3, 2017	S	69,427	$22.72	D	60,000	D
Common Stock	May 3, 2017	M	30,573	$1.90	A	90,573	D
Common Stock	May 3, 2017	S	30,573	$22.55	D	60,000	D
Common Stock	May 4, 2017	M	59,149	$1.90	A	119,149	D
Common Stock^F3	May 4, 2017	S	59,149	$22.17	D	60,000	D
Common Stock	May 5, 2017	M	89,555	$1.90	A	149,555	D
Common Stock^F4	May 5, 2017	S	89,555	$21.87	D	60,000	D
Common Stock	May 5, 2017	M	10,445	$1.90	A	70,445	D
Common Stock^F5	May 5, 2017	S	10,445	$21.65	D	60,000	D
Common Stock^F6	holding	—	—		—	172,698	I	By Trust
Common Stock^F7	holding	—	—		—	16,970	I	By 401(k)

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F8	$1.90	May 3, 2017	M	69,427	D	Jul 20, 2015	Feb 4, 2022	Common Stock	69,427	380,573	D
Option (right to buy)^F8	$1.90	May 3, 2017	M	30,573	D	Jul 20, 2015	Feb 4, 2022	Common Stock	30,573	350,000	D
Option (right to buy)^F8	$1.90	May 4, 2017	M	59,149	D	Jul 20, 2015	Feb 4, 2022	Common Stock	59,149	290,851	D
Option (right to buy)^F8	$1.90	May 5, 2017	M	89,555	D	Jul 20, 2015	Feb 4, 2022	Common Stock	89,555	201,296	D
Option (right to buy)^F8	$1.90	May 5, 2017	M	10,445	D	Jul 20, 2015	Feb 4, 2022	Common Stock	10,445	190,851	D

Explanation of responses

F1Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.70 to $22.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.15 to $22.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.85 to $21.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.65 to $21.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
F6Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F7Represents 16,970 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 2, 2017.
F8The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.